My WebLink
|
Help
|
About
|
Sign Out
Home
Search
04-24-2023 City Council Packet
LinoLakes
>
City Council
>
City Council Meeting Packets
>
2023
>
Searchable Packets
>
04-24-2023 City Council Packet
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/26/2023 12:57:52 PM
Creation date
4/26/2023 12:56:27 PM
Metadata
Fields
Template:
City Council
Council Document Type
Council Packet
Meeting Date
04/24/2023
Council Meeting Type
Regular
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
115
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
7 <br />D.Local government grantmaking. Participating Local Governments may make contracts <br />with or grants to a nonprofit, charity, or other entity with Opioid Settlement Funds. <br />E.Interest earned on special revenue fund . The funds in the special revenue fund may be <br />invested, consistent with the investment limitations for local governments, and may be <br />placed in an interest-bearing bank account. Any interest earned on the special revenue <br />funds must be used in a way that is consistent with this MOA. <br />IV.Opioid Remediation Activities <br />A.Limitation on use of funds . This MOA requires that Opioid Settlement Funds be utilized <br />only for future opioid remediation activities, and Parties shall expend Opioid Settlement <br />Funds only for Approved Uses and for expenditures incurred after the effective date of <br />this MOA, unless execution of the National Settlement Agreements requires a later date. <br />Opioid Settlement Funds cannot be used to pay litigation costs, expenses, or attorney fees <br />arising from the enforcement of legal claims related to the opioid epidemic, except for the <br />portion of Opioid Settlement Funds that comprise the Backstop Fund described in Section <br />VI. For the avoidance of doubt, counsel for Litigating Local Governments may recover <br />litigation costs, expenses, or attorney fees from the common benefit, contingency fee, and <br />cost funds established in the National Settlement Agreements, as well as the Backstop <br />Fund described in Section VI. <br />B.Public health departments as Chief Strategists. For Participating Local Governments that <br />have public health departments, the public health departments shall serve as the lead <br />agency and Chief Strategist to identify, collaborate, and respond to local issues as Local <br />Governments decide how to leverage and disburse Opioid Settlement Funds. In their role <br />as Chief Strategist, public health departments will convene multi-sector meetings and <br />lead efforts that build upon local efforts like Community Health Assessments and <br />Community Health Improvement Plans, while fostering community focused and <br />collaborative evidence-informed approaches that prevent and address addiction across the <br />areas of public health, human services, and public safety. Chief Strategists should consult <br />with municipalities located within their county in the development of any Community <br />Health Assessment, and are encouraged to collaborate with law enforcement agencies in <br />the county where appropriate. <br />C.Administrative expenses. Reasonable administrative costs for the State or Local <br />Government to administer its allocation of the Opioid Settlement Funds shall not exceed <br />actual costs, 10% of the relevant allocation of the Opioid Settlement Funds, or any <br />administrative expense limitation imposed by the National Settlement Agreements or <br />Bankruptcy Resolution, whichever is less. <br />D.Regions . Two or more Participating Local Governments may at their discretion form a <br />new group or utilize an existing group (“Region”) to pool their respective shares of <br />settlement funds and make joint spending decisions. Participating Local Governments <br />may <br />DocuSign Envelope ID: 040056EC-0D41-4D98-9C65-E01AE876A6AB
The URL can be used to link to this page
Your browser does not support the video tag.